VEGFA and neoplasm: While the increase in tumor enhancement may coincide with functional changes in the individual, it is not reflective of a true increase in disease burden and often resolves within months without any treatment change.6 Pseudoresponse is defined by a decrease in tumor enhancement after starting treatment with antiangiogenic agents (eg, VEGF inhibitor) that is not reflective of a true decrease in disease burden.